Ellsworth Advisors LLC raised its stake in shares of The Cigna Group (NYSE:CI - Free Report) by 24.4% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 18,864 shares of the health services provider's stock after purchasing an additional 3,697 shares during the period. The Cigna Group accounts for 1.4% of Ellsworth Advisors LLC's portfolio, making the stock its 24th largest position. Ellsworth Advisors LLC's holdings in The Cigna Group were worth $5,209,000 as of its most recent filing with the SEC.
Several other institutional investors also recently made changes to their positions in the stock. ORG Wealth Partners LLC acquired a new stake in shares of The Cigna Group during the fourth quarter valued at about $34,000. Ulland Investment Advisors LLC lifted its position in shares of The Cigna Group by 2,500.0% during the third quarter. Ulland Investment Advisors LLC now owns 104 shares of the health services provider's stock worth $36,000 after purchasing an additional 100 shares during the last quarter. Prospera Private Wealth LLC acquired a new position in shares of The Cigna Group in the 3rd quarter worth approximately $37,000. Harbor Capital Advisors Inc. bought a new stake in shares of The Cigna Group in the 3rd quarter valued at approximately $45,000. Finally, Intact Investment Management Inc. acquired a new stake in shares of The Cigna Group during the 3rd quarter valued at approximately $69,000. 86.99% of the stock is owned by hedge funds and other institutional investors.
The Cigna Group Price Performance
NYSE:CI traded up $3.19 during mid-day trading on Monday, reaching $284.16. 1,892,393 shares of the stock were exchanged, compared to its average volume of 1,847,029. The Cigna Group has a 1-year low of $262.03 and a 1-year high of $370.83. The company has a current ratio of 0.72, a quick ratio of 0.72 and a debt-to-equity ratio of 0.71. The firm has a market capitalization of $79.04 billion, a PE ratio of 26.81, a PEG ratio of 0.75 and a beta of 0.54. The business has a fifty day moving average price of $301.37 and a 200 day moving average price of $326.80.
The Cigna Group (NYSE:CI - Get Free Report) last announced its quarterly earnings data on Thursday, October 31st. The health services provider reported $7.51 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.22 by $0.29. The company had revenue of $63.70 billion for the quarter, compared to analysts' expectations of $59.58 billion. The Cigna Group had a net margin of 1.31% and a return on equity of 18.42%. The business's revenue was up 29.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $6.77 EPS. Research analysts expect that The Cigna Group will post 28.5 earnings per share for the current fiscal year.
The Cigna Group Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Thursday, December 19th. Shareholders of record on Wednesday, December 4th were paid a dividend of $1.40 per share. This represents a $5.60 dividend on an annualized basis and a yield of 1.97%. The ex-dividend date was Wednesday, December 4th. The Cigna Group's dividend payout ratio is presently 52.83%.
Analysts Set New Price Targets
Several research firms have weighed in on CI. Piper Sandler reiterated an "overweight" rating and set a $394.00 target price (up previously from $392.00) on shares of The Cigna Group in a research note on Tuesday, November 5th. Truist Financial lowered their price objective on shares of The Cigna Group from $420.00 to $390.00 and set a "buy" rating for the company in a research report on Monday, January 6th. StockNews.com cut shares of The Cigna Group from a "strong-buy" rating to a "buy" rating in a report on Monday, November 4th. Stephens reaffirmed an "overweight" rating and set a $410.00 target price on shares of The Cigna Group in a report on Friday, November 1st. Finally, Deutsche Bank Aktiengesellschaft cut their price target on The Cigna Group from $398.00 to $394.00 and set a "buy" rating on the stock in a report on Monday, November 4th. One research analyst has rated the stock with a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Buy" and an average price target of $395.93.
Get Our Latest Stock Analysis on The Cigna Group
The Cigna Group Company Profile
(
Free Report)
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Featured Stories
Before you consider The Cigna Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Cigna Group wasn't on the list.
While The Cigna Group currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
